Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
-
In war-split Myanmar 'spirit consorts' commune across divide
-
Number of missing in Nepal, China floods soars past 2,400
-
Leaders of Russia, China, Iran to attend summit in Kyrgyzstan
-
Trump announces deal for huge US stake in Venezuelan oil reserves
-
Hovland and Gerard share lead at Tour Championship
-
Kane confirms talks on Bayern extension
-
Maresca salutes 'unbelievable' Cherki after Man City star sinks Palace
-
Trump govt. mulls deal to give away part of Yosemite park
-
Marquinhos rescues last-gasp draw for PSG at Lille in Ligue 1
-
Indian release of Sonia Gandhi memoir uncertain after publisher clarification
-
ICE detains British far-right activist Milo Yiannopoulos in Louisiana
-
Cities show cleaner transport policies can reduce severe air pollution
-
Milo Yiannopoulos held by ICE after missing immigration hearing
-
Four patients harmed in Nashville hospital medication mix-up
-
Six Flags closes X2 rollercoaster after reports of severe brain injuries
-
Essex council hires private guards as Wethersfield asylum centre expands
-
Jury ends second day without verdict in Lindsay Clancy murder trial
-
Haakon VIII becomes Norway's king after Harald V dies at 89
-
Artist says criticised Ronnie O'Sullivan mural is unfinished
-
Six injured after sign falls at Christian festival in West Sussex
-
UAE grants Starlink 10-year satellite broadband licence
-
Dubai airport expands scanners that keep laptops and liquids in bags
-
US says Hormuz mines cleared as diplomacy and military deployments continue
-
Kuwait and Pakistan sign military cooperation agreement
-
Nepal-Tibet flood toll reaches 584 as more than 2,400 remain missing
-
Ramos strikes as AC Milan beat Venezia
-
Cherki makes his point to Maresca as Man City sparkle in Palace rout
-
Odisha faces very heavy rain as Sri Ganganagar reaches 41.4C
-
COP17 soil assessment links worsening land degradation to food and nutrition risks
-
Scammers in China exploit Microsoft Teams and other workplace apps to target victims
-
Medical AI paper predicts autonomous systems could outperform doctors in core clinical tasks by 2030
-
GSA employees report mice, ceiling damage and cloudy water after Washington office move
-
REI Labor Day sale runs through September 7 with outdoor gear discounts
-
Cara and former scraper develop open-source tool to alert artists when work appears in AI datasets
-
Meta tests robots for cabling, server resets and maintenance inside data centers
-
Google expands easier file sharing between Android phones and Apple devices
-
Nepal-Tibet flood rescue resumes after overflowing debris lake forces temporary withdrawal
-
UK chefs turn to induction cooking to reduce kitchen heat, energy use and pollution
-
Extreme heat exposes vulnerabilities across Britain's rail network
-
Restored Cheshire wetland becomes key UK breeding site for black-necked grebes
-
Dollar rallies after Fed chief lifts rate expectations
-
Bayern steamroll Stuttgart in Bundesliga opener
-
Slumping Sabalenka 'confident' ahead of US Open three-peat bid
-
England pace quartet might keep Archer going until he is 40
-
Aston Villa seal swoop for Chelsea striker Jackson
-
Driven by distraction? Trump steps up stunts as US midterms loom
-
Number of missing in deadly Nepal, China floods jumps past 2,400
-
Springboks a wounded beast, warns All Blacks captain Savea
-
Birmingham City Seek First Championship Win Against Wrexham
-
Trump announces new US 'Space Academy'
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the second quarter ended October 31, 2025, on Monday, December 15, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 691139. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 53331, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Gavin Cooper - Vice President, Global Marketing
[email protected]
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
P.Hernandez--AT
